600276 logo

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Stock Price

SHSE:600276 Community·CN¥417.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

600276 Share Price Performance

CN¥62.90
15.20 (31.87%)
CN¥62.90
15.20 (31.87%)
Price CN¥62.90

600276 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

1 Risk
2 Rewards

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Key Details

CN¥31.0b

Revenue

CN¥4.2b

Cost of Revenue

CN¥26.7b

Gross Profit

CN¥19.3b

Other Expenses

CN¥7.5b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.13
86.31%
24.10%
0%
View Full Analysis

About 600276

Founded
1970
Employees
20238
CEO
Ji Feng
WebsiteView website
www.hengrui.com

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Recent 600276 News & Updates

Recent updates

No updates